| Product Code: ETC7742246 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Medication Assisted Treatment Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Medication Assisted Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Medication Assisted Treatment Market - Industry Life Cycle |
3.4 Japan Medication Assisted Treatment Market - Porter's Five Forces |
3.5 Japan Medication Assisted Treatment Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.6 Japan Medication Assisted Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Japan Medication Assisted Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Japan Medication Assisted Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Japan Medication Assisted Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of medication-assisted treatment (MAT) in Japan |
4.2.2 Growing government initiatives to combat substance abuse and opioid addiction |
4.2.3 Rise in the prevalence of opioid addiction and the need for effective treatment options |
4.3 Market Restraints |
4.3.1 Stigma associated with MAT among patients and healthcare providers |
4.3.2 Limited availability of trained healthcare professionals for administering MAT |
4.3.3 Regulatory challenges and strict guidelines for prescribing MAT medications |
5 Japan Medication Assisted Treatment Market Trends |
6 Japan Medication Assisted Treatment Market, By Types |
6.1 Japan Medication Assisted Treatment Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 Japan Medication Assisted Treatment Market Revenues & Volume, By Products, 2021- 2031F |
6.1.3 Japan Medication Assisted Treatment Market Revenues & Volume, By Buprenorphine and Naloxone, 2021- 2031F |
6.1.4 Japan Medication Assisted Treatment Market Revenues & Volume, By Naltrexone, 2021- 2031F |
6.1.5 Japan Medication Assisted Treatment Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.6 Japan Medication Assisted Treatment Market Revenues & Volume, By Methadone, 2021- 2031F |
6.2 Japan Medication Assisted Treatment Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Japan Medication Assisted Treatment Market Revenues & Volume, By Generics, 2021- 2031F |
6.2.3 Japan Medication Assisted Treatment Market Revenues & Volume, By Branded, 2021- 2031F |
6.3 Japan Medication Assisted Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Japan Medication Assisted Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Japan Medication Assisted Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Japan Medication Assisted Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Medication Assisted Treatment Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Japan Medication Assisted Treatment Market Revenues & Volume, By Rehabilitation Clinics, 2021- 2031F |
6.4.3 Japan Medication Assisted Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Japan Medication Assisted Treatment Market Revenues & Volume, By Specialty Centers, 2021- 2031F |
6.4.5 Japan Medication Assisted Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.6 Japan Medication Assisted Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Medication Assisted Treatment Market Import-Export Trade Statistics |
7.1 Japan Medication Assisted Treatment Market Export to Major Countries |
7.2 Japan Medication Assisted Treatment Market Imports from Major Countries |
8 Japan Medication Assisted Treatment Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare facilities offering MAT services |
8.2 Patient retention rate in MAT programs |
8.3 Average waiting time for patients to access MAT services |
9 Japan Medication Assisted Treatment Market - Opportunity Assessment |
9.1 Japan Medication Assisted Treatment Market Opportunity Assessment, By Products, 2021 & 2031F |
9.2 Japan Medication Assisted Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Japan Medication Assisted Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Japan Medication Assisted Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Japan Medication Assisted Treatment Market - Competitive Landscape |
10.1 Japan Medication Assisted Treatment Market Revenue Share, By Companies, 2024 |
10.2 Japan Medication Assisted Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here